| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |